ID   SC6A3_HUMAN             Reviewed;         620 AA.
AC   Q01959; A2RUN4; Q14996;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1993, sequence version 1.
DT   10-MAY-2017, entry version 180.
DE   RecName: Full=Sodium-dependent dopamine transporter;
DE            Short=DA transporter;
DE            Short=DAT;
DE   AltName: Full=Solute carrier family 6 member 3;
GN   Name=SLC6A3; Synonyms=DAT1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=1359373; DOI=10.1016/0169-328X(92)90165-8;
RA   Vandenbergh D.J., Persico A.M., Uhl G.R.;
RT   "A human dopamine transporter cDNA predicts reduced glycosylation,
RT   displays a novel repetitive element and provides racially-dimorphic
RT   TaqI RFLPs.";
RL   Brain Res. Mol. Brain Res. 15:161-166(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND SUBCELLULAR LOCATION.
RC   TISSUE=Brain;
RX   PubMed=1406597;
RA   Giros B., el Mestikawy S., Godinot N., Zheng K., Han H., Yang-Feng T.,
RA   Caron M.G.;
RT   "Cloning, pharmacological characterization, and chromosome assignment
RT   of the human dopamine transporter.";
RL   Mol. Pharmacol. 42:383-390(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND SUBCELLULAR LOCATION.
RC   TISSUE=Brain;
RX   PubMed=8302271;
RA   Pristupa Z.B., Wilson J.M., Hoffman B.J., Kish S.J., Niznik H.B.;
RT   "Pharmacological heterogeneity of the cloned and native human dopamine
RT   transporter: disassociation of [3H]WIN 35,428 and [3H]GBR 12,935
RT   binding.";
RL   Mol. Pharmacol. 45:125-135(1994).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=9300814; DOI=10.1016/S0378-1119(97)00131-5;
RA   Kawarai T., Kawakami H., Yamamura Y., Nakamura S.;
RT   "Structure and organization of the gene encoding human dopamine
RT   transporter.";
RL   Gene 195:11-18(1997).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=10889531; DOI=10.1038/sj.mp.4000701;
RA   Vandenbergh D.J., Thompson M.D., Cook E.H., Bendahhou E., Nguyen T.,
RA   Krasowski M.D., Zarrabian D., Comings D., Sellers E.M., Tyndale R.F.,
RA   George S.R., O'Dowd B.F., Uhl G.R.;
RT   "Human dopamine transporter gene: coding region conservation among
RT   normal, Tourette's disorder, alcohol dependence and attention-deficit
RT   hyperactivity disorder populations.";
RL   Mol. Psychiatry 5:283-292(2000).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=11304827;
RX   DOI=10.1002/1096-8628(2001)9999:9999<::AID-AJMG1161>3.0.CO;2-8;
RA   Greenwood T.A., Alexander M., Keck P.E., McElroy S., Sadovnick A.D.,
RA   Remick R.A., Kelsoe J.R.;
RT   "Evidence for linkage disequilibrium between the dopamine transporter
RT   and bipolar disorder.";
RL   Am. J. Med. Genet. 105:145-151(2001).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=17934207; DOI=10.1093/molbev/msm219;
RA   Miller-Butterworth C.M., Kaplan J.R., Shaffer J., Devlin B.,
RA   Manuck S.B., Ferrell R.E.;
RT   "Sequence variation in the primate dopamine transporter gene and its
RT   relationship to social dominance.";
RL   Mol. Biol. Evol. 25:18-28(2008).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NIEHS SNPs program;
RL   Submitted (MAY-2004) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [11]
RP   PRELIMINARY NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-385, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=7637582; DOI=10.1016/0169-328X(95)00018-N;
RA   Donovan D.M., Vandenbergh D.J., Perry M.P., Bird G.S., Ingersoll R.,
RA   Nanthakumar E., Uhl G.R.;
RT   "Human and mouse dopamine transporter genes: conservation of 5'-
RT   flanking sequence elements and gene structures.";
RL   Brain Res. Mol. Brain Res. 30:327-335(1995).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 164-255.
RX   PubMed=1353885; DOI=10.1073/pnas.89.15.7095;
RA   Bannon M.J., Poosch M.S., Xia Y., Goebel D.J., Cassin B., Kapatos G.;
RT   "Dopamine transporter mRNA content in human substantia nigra decreases
RT   precipitously with age.";
RL   Proc. Natl. Acad. Sci. U.S.A. 89:7095-7099(1992).
RN   [13]
RP   INTERACTION WITH PRKCABP.
RX   PubMed=11343649; DOI=10.1016/S0896-6273(01)00267-7;
RA   Torres G.E., Yao W.-D., Mohn A.R., Quan H., Kim K.-M., Levey A.I.,
RA   Staudinger J., Caron M.G.;
RT   "Functional interaction between monoamine plasma membrane transporters
RT   and the synaptic PDZ domain-containing protein PICK1.";
RL   Neuron 30:121-134(2001).
RN   [14]
RP   INTERCHAIN DISULFIDE BOND, AND SUBUNIT.
RA   Hastrup H., Karlin A., Javitch J.A.;
RT   "Symmetrical homodimer of the human dopamine transporter revealed by
RT   cross-linking Cys306 at the extracellular end of TM6.";
RL   Abstr. - Soc. Neurosci. 27:1866-1866(2001).
RN   [15]
RP   INTERACTION WITH TGFB1I1.
RX   PubMed=12177201;
RA   Carneiro A.M.D., Ingram S.L., Beaulieu J.-M., Sweeney A., Amara S.G.,
RA   Thomas S.M., Caron M.G., Torres G.E.;
RT   "The multiple LIM domain-containing adaptor protein Hic-5 synaptically
RT   colocalizes and interacts with the dopamine transporter.";
RL   J. Neurosci. 22:7045-7054(2002).
RN   [16]
RP   FUNCTION AS DOPAMINE TRANSPORTER, INTERACTION WITH TOR1A, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=15505207; DOI=10.1073/pnas.0308088101;
RA   Torres G.E., Sweeney A.L., Beaulieu J.M., Shashidharan P., Caron M.G.;
RT   "Effect of torsinA on membrane proteins reveals a loss of function and
RT   a dominant-negative phenotype of the dystonia-associated DeltaE-
RT   torsinA mutant.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:15650-15655(2004).
RN   [17]
RP   VARIANT GLN-237.
RX   PubMed=10391209; DOI=10.1038/10290;
RA   Cargill M., Altshuler D., Ireland J., Sklar P., Ardlie K., Patil N.,
RA   Shaw N., Lane C.R., Lim E.P., Kalyanaraman N., Nemesh J., Ziaugra L.,
RA   Friedland L., Rolfe A., Warrington J., Lipshutz R., Daley G.Q.,
RA   Lander E.S.;
RT   "Characterization of single-nucleotide polymorphisms in coding regions
RT   of human genes.";
RL   Nat. Genet. 22:231-238(1999).
RN   [18]
RP   ERRATUM.
RA   Cargill M., Altshuler D., Ireland J., Sklar P., Ardlie K., Patil N.,
RA   Shaw N., Lane C.R., Lim E.P., Kalyanaraman N., Nemesh J., Ziaugra L.,
RA   Friedland L., Rolfe A., Warrington J., Lipshutz R., Daley G.Q.,
RA   Lander E.S.;
RL   Nat. Genet. 23:373-373(1999).
RN   [19]
RP   VARIANTS [LARGE SCALE ANALYSIS] SER-121 AND SER-544.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
RN   [20]
RP   VARIANTS PKDYS GLN-368 AND LEU-395, AND CHARACTERIZATION OF VARIANTS
RP   PKDYS GLN-368 AND LEU-395.
RX   PubMed=19478460; DOI=10.1172/JCI39060;
RA   Kurian M.A., Zhen J., Cheng S.Y., Li Y., Mordekar S.R., Jardine P.,
RA   Morgan N.V., Meyer E., Tee L., Pasha S., Wassmer E., Heales S.J.,
RA   Gissen P., Reith M.E., Maher E.R.;
RT   "Homozygous loss-of-function mutations in the gene encoding the
RT   dopamine transporter are associated with infantile parkinsonism-
RT   dystonia.";
RL   J. Clin. Invest. 119:1595-1603(2009).
RN   [21]
RP   VARIANT ILE-471.
RX   PubMed=21179162; DOI=10.1038/nature09629;
RA   Bevilacqua L., Doly S., Kaprio J., Yuan Q., Tikkanen R., Paunio T.,
RA   Zhou Z., Wedenoja J., Maroteaux L., Diaz S., Belmer A.,
RA   Hodgkinson C.A., Dell'osso L., Suvisaari J., Coccaro E., Rose R.J.,
RA   Peltonen L., Virkkunen M., Goldman D.;
RT   "A population-specific HTR2B stop codon predisposes to severe
RT   impulsivity.";
RL   Nature 468:1061-1066(2010).
CC   -!- FUNCTION: Amine transporter. Terminates the action of dopamine by
CC       its high affinity sodium-dependent reuptake into presynaptic
CC       terminals. {ECO:0000269|PubMed:1406597,
CC       ECO:0000269|PubMed:15505207, ECO:0000269|PubMed:8302271}.
CC   -!- SUBUNIT: Homooligomer; disulfide-linked (Ref.14). Interacts with
CC       PRKCABP and TGFB1I1 (PubMed:11343649, PubMed:12177201). Interacts
CC       (via N-terminus) with SYNGR3 (via N-terminus). Interacts with
CC       SLC18A2. Interacts with TOR1A (ATP-bound); TOR1A regulates SLC6A3
CC       subcellular location (By similarity).
CC       {ECO:0000250|UniProtKB:Q61327, ECO:0000269|PubMed:11343649,
CC       ECO:0000269|PubMed:12177201, ECO:0000269|PubMed:15505207,
CC       ECO:0000269|Ref.14}.
CC   -!- INTERACTION:
CC       P14416:DRD2; NbExp=4; IntAct=EBI-6661445, EBI-2928178;
CC       P37840:SNCA; NbExp=3; IntAct=EBI-6661445, EBI-985879;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:1406597,
CC       ECO:0000269|PubMed:15505207, ECO:0000269|PubMed:8302271}; Multi-
CC       pass membrane protein {ECO:0000269|PubMed:15505207}.
CC   -!- TISSUE SPECIFICITY: Highly expressed in substantia nigra.
CC       {ECO:0000269|PubMed:7637582}.
CC   -!- DISEASE: Parkinsonism-dystonia infantile (PKDYS) [MIM:613135]: A
CC       neurodegenerative disorder characterized by infantile onset of
CC       parkinsonism and dystonia. Other neurologic features include
CC       global developmental delay, bradykinesia and pyramidal tract
CC       signs. {ECO:0000269|PubMed:19478460}. Note=The disease is caused
CC       by mutations affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: This protein is the target of psychomotor
CC       stimulants such as amphetamines or cocaine.
CC   -!- SIMILARITY: Belongs to the sodium:neurotransmitter symporter (SNF)
CC       (TC 2.A.22) family. SLC6A3 subfamily. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/slc6a3/";
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Dopamine transporter entry;
CC       URL="https://en.wikipedia.org/wiki/Dopamine_transporter";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M95167; AAC41720.1; -; mRNA.
DR   EMBL; S46955; AAA11754.1; -; mRNA.
DR   EMBL; S44626; AAB23443.1; -; mRNA.
DR   EMBL; L24178; AAA19560.1; -; mRNA.
DR   EMBL; D88570; BAA22511.1; -; Genomic_DNA.
DR   EMBL; AF119117; AAC50179.2; -; Genomic_DNA.
DR   EMBL; AF321321; AAG33844.1; -; Genomic_DNA.
DR   EMBL; AF306558; AAG33844.1; JOINED; Genomic_DNA.
DR   EMBL; AF321320; AAG33844.1; JOINED; Genomic_DNA.
DR   EMBL; AF306559; AAG33844.1; JOINED; Genomic_DNA.
DR   EMBL; AF306560; AAG33844.1; JOINED; Genomic_DNA.
DR   EMBL; AF306561; AAG33844.1; JOINED; Genomic_DNA.
DR   EMBL; AF306562; AAG33844.1; JOINED; Genomic_DNA.
DR   EMBL; AF306563; AAG33844.1; JOINED; Genomic_DNA.
DR   EMBL; AF306564; AAG33844.1; JOINED; Genomic_DNA.
DR   EMBL; EF174603; ABO77644.1; -; mRNA.
DR   EMBL; AY623110; AAT38106.1; -; Genomic_DNA.
DR   EMBL; CH471102; EAX08159.1; -; Genomic_DNA.
DR   EMBL; BC132977; AAI32978.1; -; mRNA.
DR   EMBL; BC133003; AAI33004.1; -; mRNA.
DR   EMBL; M96670; AAA35770.1; -; mRNA.
DR   CCDS; CCDS3863.1; -.
DR   PIR; A48980; A48980.
DR   PIR; I57937; I57937.
DR   PIR; I84455; I84455.
DR   RefSeq; NP_001035.1; NM_001044.4.
DR   UniGene; Hs.406; -.
DR   ProteinModelPortal; Q01959; -.
DR   SMR; Q01959; -.
DR   BioGrid; 112422; 13.
DR   DIP; DIP-41827N; -.
DR   IntAct; Q01959; 4.
DR   MINT; MINT-576917; -.
DR   STRING; 9606.ENSP00000270349; -.
DR   BindingDB; Q01959; -.
DR   ChEMBL; CHEMBL238; -.
DR   DrugBank; DB01472; 4-Methoxyamphetamine.
DR   DrugBank; DB04947; Altropane.
DR   DrugBank; DB00543; Amoxapine.
DR   DrugBank; DB00182; Amphetamine.
DR   DrugBank; DB06413; Armodafinil.
DR   DrugBank; DB00289; Atomoxetine.
DR   DrugBank; DB00245; Benzatropine.
DR   DrugBank; DB00865; Benzphetamine.
DR   DrugBank; DB01156; Bupropion.
DR   DrugBank; DB01161; Chloroprocaine.
DR   DrugBank; DB01114; Chlorphenamine.
DR   DrugBank; DB00215; Citalopram.
DR   DrugBank; DB00907; Cocaine.
DR   DrugBank; DB06701; Dexmethylphenidate.
DR   DrugBank; DB01576; Dextroamphetamine.
DR   DrugBank; DB00937; Diethylpropion.
DR   DrugBank; DB01146; Diphenylpyraline.
DR   DrugBank; DB00988; Dopamine.
DR   DrugBank; DB00476; Duloxetine.
DR   DrugBank; DB01363; Ephedra.
DR   DrugBank; DB01175; Escitalopram.
DR   DrugBank; DB01463; Fencamfamine.
DR   DrugBank; DB00458; Imipramine.
DR   DrugBank; DB08824; Ioflupane I-123.
DR   DrugBank; DB01255; Lisdexamfetamine.
DR   DrugBank; DB00408; Loxapine.
DR   DrugBank; DB00579; Mazindol.
DR   DrugBank; DB01577; Methamphetamine.
DR   DrugBank; DB00422; Methylphenidate.
DR   DrugBank; DB06148; Mianserin.
DR   DrugBank; DB00370; Mirtazapine.
DR   DrugBank; DB01442; MMDA.
DR   DrugBank; DB00745; Modafinil.
DR   DrugBank; DB01149; Nefazodone.
DR   DrugBank; DB04821; Nomifensine.
DR   DrugBank; DB00454; Pethidine.
DR   DrugBank; DB00830; Phenmetrazine.
DR   DrugBank; DB00191; Phentermine.
DR   DrugBank; DB00721; Procaine.
DR   DrugBank; DB00852; Pseudoephedrine.
DR   DrugBank; DB01104; Sertraline.
DR   DrugBank; DB01105; Sibutramine.
DR   DrugBank; DB00726; Trimipramine.
DR   DrugBank; DB00285; Venlafaxine.
DR   GuidetoPHARMACOLOGY; 927; -.
DR   TCDB; 2.A.22.1.3; the neurotransmitter:sodium symporter (nss) family.
DR   iPTMnet; Q01959; -.
DR   PhosphoSitePlus; Q01959; -.
DR   BioMuta; SLC6A3; -.
DR   DMDM; 266667; -.
DR   PaxDb; Q01959; -.
DR   PeptideAtlas; Q01959; -.
DR   PRIDE; Q01959; -.
DR   Ensembl; ENST00000270349; ENSP00000270349; ENSG00000142319.
DR   Ensembl; ENST00000621716; ENSP00000479597; ENSG00000276996.
DR   GeneID; 6531; -.
DR   KEGG; hsa:6531; -.
DR   UCSC; uc003jck.4; human.
DR   CTD; 6531; -.
DR   DisGeNET; 6531; -.
DR   GeneCards; SLC6A3; -.
DR   HGNC; HGNC:11049; SLC6A3.
DR   HPA; CAB016249; -.
DR   HPA; CAB078172; -.
DR   HPA; HPA013602; -.
DR   MalaCards; SLC6A3; -.
DR   MIM; 126455; gene.
DR   MIM; 613135; phenotype.
DR   neXtProt; NX_Q01959; -.
DR   OpenTargets; ENSG00000142319; -.
DR   Orphanet; 238455; Infantile dystonia-parkinsonism.
DR   PharmGKB; PA311; -.
DR   eggNOG; KOG3659; Eukaryota.
DR   eggNOG; COG0733; LUCA.
DR   GeneTree; ENSGT00760000118857; -.
DR   HOGENOM; HOG000116406; -.
DR   HOVERGEN; HBG071421; -.
DR   InParanoid; Q01959; -.
DR   KO; K05036; -.
DR   OMA; YAAYKFC; -.
DR   OrthoDB; EOG091G08PX; -.
DR   PhylomeDB; Q01959; -.
DR   TreeFam; TF343812; -.
DR   Reactome; R-HSA-379401; Dopamine clearance from the synaptic cleft.
DR   Reactome; R-HSA-442660; Na+/Cl- dependent neurotransmitter transporters.
DR   SABIO-RK; Q01959; -.
DR   GeneWiki; Dopamine_transporter; -.
DR   GenomeRNAi; 6531; -.
DR   PMAP-CutDB; Q01959; -.
DR   PRO; PR:Q01959; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000142319; -.
DR   CleanEx; HS_SLC6A3; -.
DR   Genevisible; Q01959; HS.
DR   GO; GO:0030424; C:axon; IDA:UniProtKB.
DR   GO; GO:0009986; C:cell surface; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; TAS:ProtInc.
DR   GO; GO:0016600; C:flotillin complex; IDA:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; TAS:ProtInc.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0045121; C:membrane raft; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0043005; C:neuron projection; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0043025; C:neuronal cell body; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0098793; C:presynapse; IEA:GOC.
DR   GO; GO:0035240; F:dopamine binding; IEA:Ensembl.
DR   GO; GO:0005329; F:dopamine transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0005330; F:dopamine:sodium symporter activity; IBA:GO_Central.
DR   GO; GO:0008144; F:drug binding; IEA:Ensembl.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0008504; F:monoamine transmembrane transporter activity; IDA:MGI.
DR   GO; GO:0002020; F:protease binding; IEA:Ensembl.
DR   GO; GO:0032403; F:protein complex binding; IEA:Ensembl.
DR   GO; GO:0047485; F:protein N-terminus binding; IEA:Ensembl.
DR   GO; GO:0051721; F:protein phosphatase 2A binding; IEA:Ensembl.
DR   GO; GO:0005102; F:receptor binding; IEA:Ensembl.
DR   GO; GO:0021984; P:adenohypophysis development; IEA:Ensembl.
DR   GO; GO:0007568; P:aging; IEA:Ensembl.
DR   GO; GO:0042416; P:dopamine biosynthetic process; IEA:Ensembl.
DR   GO; GO:0042420; P:dopamine catabolic process; IEA:Ensembl.
DR   GO; GO:0015872; P:dopamine transport; IDA:UniProtKB.
DR   GO; GO:0090494; P:dopamine uptake; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0051583; P:dopamine uptake involved in synaptic transmission; IBA:GO_Central.
DR   GO; GO:0007595; P:lactation; IEA:Ensembl.
DR   GO; GO:0007626; P:locomotory behavior; IEA:Ensembl.
DR   GO; GO:0015844; P:monoamine transport; IDA:MGI.
DR   GO; GO:0042136; P:neurotransmitter biosynthetic process; TAS:Reactome.
DR   GO; GO:0040018; P:positive regulation of multicellular organism growth; IEA:Ensembl.
DR   GO; GO:0060134; P:prepulse inhibition; IEA:Ensembl.
DR   GO; GO:0042053; P:regulation of dopamine metabolic process; IEA:Ensembl.
DR   GO; GO:0051591; P:response to cAMP; IEA:Ensembl.
DR   GO; GO:0042220; P:response to cocaine; IEA:Ensembl.
DR   GO; GO:0042493; P:response to drug; IEA:Ensembl.
DR   GO; GO:0045471; P:response to ethanol; IEA:Ensembl.
DR   GO; GO:0010039; P:response to iron ion; IEA:Ensembl.
DR   GO; GO:0035094; P:response to nicotine; IEA:Ensembl.
DR   GO; GO:0007608; P:sensory perception of smell; IEA:Ensembl.
DR   InterPro; IPR000175; Na/ntran_symport.
DR   InterPro; IPR002436; Na/ntran_symport_dopamine.
DR   PANTHER; PTHR11616; PTHR11616; 1.
DR   Pfam; PF00209; SNF; 1.
DR   PRINTS; PR01202; DOPTRANSPORT.
DR   PRINTS; PR00176; NANEUSMPORT.
DR   PROSITE; PS00610; NA_NEUROTRAN_SYMP_1; 1.
DR   PROSITE; PS00754; NA_NEUROTRAN_SYMP_2; 1.
DR   PROSITE; PS50267; NA_NEUROTRAN_SYMP_3; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Complete proteome; Disease mutation; Disulfide bond;
KW   Dystonia; Glycoprotein; Membrane; Metal-binding; Neurodegeneration;
KW   Neurotransmitter transport; Parkinsonism; Polymorphism;
KW   Reference proteome; Sodium; Symport; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN         1    620       Sodium-dependent dopamine transporter.
FT                                /FTId=PRO_0000214751.
FT   TOPO_DOM      1     68       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     69     89       Helical; Name=1. {ECO:0000255}.
FT   TRANSMEM     96    116       Helical; Name=2. {ECO:0000255}.
FT   TRANSMEM    140    160       Helical; Name=3. {ECO:0000255}.
FT   TOPO_DOM    161    237       Extracellular. {ECO:0000255}.
FT   TRANSMEM    238    256       Helical; Name=4. {ECO:0000255}.
FT   TRANSMEM    265    282       Helical; Name=5. {ECO:0000255}.
FT   TRANSMEM    318    335       Helical; Name=6. {ECO:0000255}.
FT   TRANSMEM    347    368       Helical; Name=7. {ECO:0000255}.
FT   TRANSMEM    401    420       Helical; Name=8. {ECO:0000255}.
FT   TRANSMEM    447    465       Helical; Name=9. {ECO:0000255}.
FT   TRANSMEM    481    501       Helical; Name=10. {ECO:0000255}.
FT   TRANSMEM    522    541       Helical; Name=11. {ECO:0000255}.
FT   TRANSMEM    560    578       Helical; Name=12. {ECO:0000255}.
FT   TOPO_DOM    579    620       Cytoplasmic. {ECO:0000255}.
FT   REGION      561    590       Interaction with TGFB1I1.
FT                                {ECO:0000269|PubMed:12177201}.
FT   METAL        75     75       Sodium 1; via carbonyl oxygen.
FT                                {ECO:0000250|UniProtKB:Q7K4Y6}.
FT   METAL        77     77       Sodium 2; via carbonyl oxygen.
FT                                {ECO:0000250|UniProtKB:Q7K4Y6}.
FT   METAL        78     78       Sodium 1; via carbonyl oxygen.
FT                                {ECO:0000250|UniProtKB:Q7K4Y6}.
FT   METAL        82     82       Sodium 2. {ECO:0000250|UniProtKB:Q7K4Y6}.
FT   METAL       321    321       Sodium 2. {ECO:0000250|UniProtKB:Q7K4Y6}.
FT   METAL       353    353       Sodium 2. {ECO:0000250|UniProtKB:Q7K4Y6}.
FT   METAL       418    418       Sodium 1; via carbonyl oxygen.
FT                                {ECO:0000250|UniProtKB:Q7K4Y6}.
FT   METAL       421    421       Sodium 1. {ECO:0000250|UniProtKB:Q7K4Y6}.
FT   METAL       422    422       Sodium 1. {ECO:0000250|UniProtKB:Q7K4Y6}.
FT   SITE        105    105       Contributes to high-affinity binding to
FT                                cocaine. {ECO:0000250|UniProtKB:Q61327}.
FT   CARBOHYD    181    181       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    188    188       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    205    205       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    180    189       {ECO:0000250|UniProtKB:Q7K4Y6}.
FT   DISULFID    306    306       Interchain. {ECO:0000269|Ref.14}.
FT   VARIANT     121    121       G -> S (in a breast cancer sample;
FT                                somatic mutation; dbSNP:rs760871529).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_036158.
FT   VARIANT     237    237       R -> Q (in dbSNP:rs6345).
FT                                {ECO:0000269|PubMed:10391209}.
FT                                /FTId=VAR_014180.
FT   VARIANT     368    368       L -> Q (in PKDYS; loss of function;
FT                                dbSNP:rs267607068).
FT                                {ECO:0000269|PubMed:19478460}.
FT                                /FTId=VAR_063771.
FT   VARIANT     395    395       P -> L (in PKDYS; loss of function;
FT                                dbSNP:rs267607069).
FT                                {ECO:0000269|PubMed:19478460}.
FT                                /FTId=VAR_063772.
FT   VARIANT     471    471       V -> I (in dbSNP:rs75916702).
FT                                {ECO:0000269|PubMed:21179162}.
FT                                /FTId=VAR_064580.
FT   VARIANT     544    544       R -> S (in a breast cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_036159.
FT   CONFLICT     35     35       K -> M (in Ref. 2; AAB23443).
FT                                {ECO:0000305}.
FT   CONFLICT    354    354       S -> C (in Ref. 2; AAB23443).
FT                                {ECO:0000305}.
SQ   SEQUENCE   620 AA;  68495 MW;  CD95009B6BA93108 CRC64;
     MSKSKCSVGL MSSVVAPAKE PNAVGPKEVE LILVKEQNGV QLTSSTLTNP RQSPVEAQDR
     ETWGKKIDFL LSVIGFAVDL ANVWRFPYLC YKNGGGAFLV PYLLFMVIAG MPLFYMELAL
     GQFNREGAAG VWKICPILKG VGFTVILISL YVGFFYNVII AWALHYLFSS FTTELPWIHC
     NNSWNSPNCS DAHPGDSSGD SSGLNDTFGT TPAAEYFERG VLHLHQSHGI DDLGPPRWQL
     TACLVLVIVL LYFSLWKGVK TSGKVVWITA TMPYVVLTAL LLRGVTLPGA IDGIRAYLSV
     DFYRLCEASV WIDAATQVCF SLGVGFGVLI AFSSYNKFTN NCYRDAIVTT SINSLTSFSS
     GFVVFSFLGY MAQKHSVPIG DVAKDGPGLI FIIYPEAIAT LPLSSAWAVV FFIMLLTLGI
     DSAMGGMESV ITGLIDEFQL LHRHRELFTL FIVLATFLLS LFCVTNGGIY VFTLLDHFAA
     GTSILFGVLI EAIGVAWFYG VGQFSDDIQQ MTGQRPSLYW RLCWKLVSPC FLLFVVVVSI
     VTFRPPHYGA YIFPDWANAL GWVIATSSMA MVPIYAAYKF CSLPGSFREK LAYAIAPEKD
     RELVDRGEVR QFTLRHWLKV
//
